A safe change from eculizumab to satralizumab in a patient with neuromyelitis optica spectrum disorder.
Kei FunakoshiKeisuke SuzukiPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
Keyphrases